{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:58:51Z","timestamp":1791496731995,"version":"4.3.4"},"reference-count":124,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T00:00:00Z","timestamp":1424908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jacc.2015.02.040","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T18:17:03Z","timestamp":1429553823000},"page":"1683-1699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Endogenous Fibrinolysis"],"prefix":"10.1016","volume":"65","author":[{"given":"Osita N.","family":"Okafor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A.","family":"Gorog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.02.040_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jacc.2005.03.074","article-title":"Atherothrombosis and high-risk plaque: part I: evolving\u00a0concepts","volume":"46","author":"Fuster","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1096\/fj.04-2748com","article-title":"Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI","volume":"19","author":"Penz","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2015.02.040_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jacc.2009.11.051","article-title":"A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques","volume":"55","author":"Reininger","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib4","first-page":"267","article-title":"Histopathological evaluation of coronary thrombi in patients with ST-segment elevation myocardial infarction","volume":"20","author":"Cambruzzi","year":"2012","journal-title":"Revista Brasileira de Cardiologia Invasiva"},{"key":"10.1016\/j.jacc.2015.02.040_bib5","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.CIR.0000157141.00778.AC","article-title":"Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention","volume":"111","author":"Rittersma","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ccd.22616","article-title":"Histopathology of aspirated thrombus and its association with ST-segment recovery in patients undergoing primary percutaneous coronary intervention with routine thrombus aspiration","volume":"77","author":"Verouden","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.02.040_bib7","doi-asserted-by":"crossref","first-page":"e5817","DOI":"10.1371\/journal.pone.0005817","article-title":"Histopathological features of aspirated thrombi after percutaneous coronary intervention in patients with ST-elevation myocardial infarction","volume":"4","author":"Kramer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2015.02.040_bib8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1053\/euhj.2002.3159","article-title":"Sudden unexpected death in young adults. Discrepancies between initiation of acute plaque complications and the onset of acute coronary death","volume":"23","author":"Henriques de","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.02.040_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.CIR.66.5.914","article-title":"Thrombolysis in acute myocardial infarction: treatment of the underlying coronary artery disease","volume":"66","author":"Swan","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ahj.2008.03.018","article-title":"Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments","volume":"156","author":"Bainey","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.02.040_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(06)68147-6","article-title":"Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.02.040_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2008.08.050","article-title":"Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction","volume":"103","author":"Fefer","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/hrt.82.3.265","article-title":"Mechanisms of progression in native coronary artery disease: role of healed plaque disruption","volume":"82","author":"Mann","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.02.040_bib14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/01.CIR.103.7.934","article-title":"Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression","volume":"103","author":"Burke","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib15","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.thromres.2012.11.029","article-title":"Whole blood clots are more resistant to lysis than plasma clots\u2014greater efficacy of rivaroxaban","volume":"131","author":"Varin","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.79.4.920","article-title":"Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis","volume":"79","author":"Jang","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib17","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.99.23.3050","article-title":"Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance","volume":"99","author":"Zhu","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1160\/TH14-01-0032","article-title":"Fibrin clot properties and their modulation in thrombotic disorders","volume":"112","author":"Undas","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0038-1657312","article-title":"Fibrin network structure: modification by platelets","volume":"49","author":"Dhall","year":"1983","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib20","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/blood-2014-06-583070","article-title":"Functional factor XIII-A is exposed on stimulated platelet surface","volume":"124","author":"Mitchell","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2015.02.040_bib21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1160\/TH14-07-0625","article-title":"Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions","volume":"113","author":"Dickneite","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jth.12455","article-title":"The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis","volume":"12","author":"Hethershaw","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib23","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1538-7836.2010.03963.x","article-title":"Model thrombi formed under flow reveal the role of factor-XIII- mediated cross-linking in resistance to fibrinolysis","volume":"8","author":"Mutch","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11239-014-1059-4","article-title":"Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease","volume":"38","author":"Kreutz","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/HJR.0b013e3280e129d0","article-title":"Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women\u2019s Heart and Health cohort study","volume":"14","author":"May","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2015.02.040_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.0000134965.73212.A6","article-title":"Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women","volume":"110","author":"Pradhan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1053\/euhj.2000.2127","article-title":"Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study","volume":"21","author":"Smith","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.02.040_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2009.03.020","article-title":"Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study","volume":"206","author":"Kinlay","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2015.02.040_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2006.11.005","article-title":"Tissue plasminogen activator on admission is an important predictor of 30-day mortality in patients with\u00a0acute myocardial infarction undergoing primary angioplasty","volume":"196","author":"Lee","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2015.02.040_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0167-5273(02)00186-9","article-title":"Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death","volume":"85","author":"Soeki","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib31","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.jacc.2009.11.095","article-title":"Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease","volume":"55","author":"Gorog","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.2005.061895","article-title":"PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting","volume":"92","author":"Marcucci","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.02.040_bib33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ehj.2003.11.004","article-title":"Tissue plasminogen activator antigen and coronary heart disease: prospective study and meta-analysis","volume":"25","author":"Lowe","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.02.040_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.21.4.611","article-title":"Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"21","author":"Folsom","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.02.040_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/jcp.12.3.215","article-title":"An evaluation of the euglobulin method for the determination of fibrinolysis","volume":"12","author":"Kowalski","year":"1959","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jacc.2015.02.040_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.thromres.2004.01.001","article-title":"A new euglobulin clot lysis assay for global fibrinolysis","volume":"112","author":"Smith","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2257.2005.00681.x","article-title":"Thrombelastography\/thromboelastometry","volume":"27","author":"Luddington","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.jacc.2015.02.040_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.2010.08223.x","article-title":"Point-of-care testing in haemostasis","volume":"150","author":"Perry","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2015.02.040_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/107602960300900208","article-title":"Value of thromboelastography in the assessment of platelet function","volume":"9","author":"Bowbrick","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1213\/00000539-199909000-00007","article-title":"Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery","volume":"89","author":"Kettner","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2015.02.040_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/1053-0770(94)90052-3","article-title":"Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay","volume":"8","author":"Tuman","year":"1994","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jacc.2015.02.040_bib42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/bja\/aen083","article-title":"Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients","volume":"100","author":"Levrat","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2015.02.040_bib43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1076029611434527","article-title":"Detection of tPA-induced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional fibrinogenTEG in healthy individuals","volume":"18","author":"Genet","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/SLA.0b013e3181f09191","article-title":"Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma","volume":"252","author":"Kashuk","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacc.2015.02.040_bib45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/TA.0b013e318280dec1","article-title":"Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid","volume":"74","author":"Dirkmann","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jacc.2015.02.040_bib46","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00000542-200111000-00021","article-title":"The effects of aprotinin on thromboelastography with three different activators","volume":"95","author":"Avidan","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2015.02.040_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00001721-200401000-00017","article-title":"Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling","volume":"15","author":"Zambruni","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1179\/102453311X13127324303515","article-title":"Comparing techniques: the use of recalcified plasma in comparison with citrated plasma alone and in combination with thrombin in ultrastructural studies","volume":"16","author":"Pretorius","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.jacc.2015.02.040_bib49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1460-9592.2004.01275.x","article-title":"The use of recalcified citrated whole blood\u2013a pragmatic approach for thromboelastography in children","volume":"14","author":"Rajwal","year":"2004","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jacc.2015.02.040_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF03017205","article-title":"Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples","volume":"55","author":"Wasowicz","year":"2008","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jacc.2015.02.040_bib51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MBC.0b013e3282f9adf9","article-title":"A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood","volume":"19","author":"Thalheimer","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/TA.0b013e31819d3caf","article-title":"Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries?","volume":"66","author":"Jeger","year":"2009","journal-title":"J Trauma"},{"key":"10.1016\/j.jacc.2015.02.040_bib53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2516.2010.02451.x","article-title":"Standardization of thromboelastography: a report from the TEG-ROTEM working group","volume":"17","author":"Chitlur","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jacc.2015.02.040_bib54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1055\/s-0030-1265292","article-title":"Quality assurance and quality control of thrombelastography and rotational thromboelastometry: the UK NEQAS for blood coagulation experience","volume":"36","author":"Kitchen","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1213\/ane.0b013e31818f8907","article-title":"Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature","volume":"108","author":"Dai","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2015.02.040_bib56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00001721-200301000-00007","article-title":"G\u00f6r\u00f6g Thrombosis Test: a global in-vitro test of platelet function and thrombolysis","volume":"14","author":"Yamamoto","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib57","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.thromres.2014.02.018","article-title":"Global\u00a0Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential","volume":"133","author":"Yamamoto","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib58","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.jbiomech.2010.07.011","article-title":"Wall shear over high degree stenoses pertinent to atherothrombosis","volume":"43","author":"Bark","year":"2010","journal-title":"J Biomech"},{"key":"10.1016\/j.jacc.2015.02.040_bib59","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1182\/blood-2006-07-028282","article-title":"Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation","volume":"109","author":"Maxwell","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2015.02.040_bib60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehs300","article-title":"Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease","volume":"34","author":"Sharma","year":"2013","journal-title":"Euro Heart J"},{"key":"10.1016\/j.jacc.2015.02.040_bib61","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.jacc.2010.01.033","article-title":"Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction","volume":"55","author":"Saraf","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib62","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0300-8932(09)70893-0","article-title":"Association of the plasminogen activator inhibitor-1 gene 4G\/5G polymorphism with ST elevation acute myocardial infarction in young patients","volume":"62","author":"Isordia-Salas","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11239-007-0083-z","article-title":"Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease","volume":"26","author":"Onalan","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib64","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","article-title":"Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study","volume":"112","author":"Smith","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib65","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/07853890109002079","article-title":"Increased plasminogen activator inhibitor activity and diabetes predict subsequent coronary events in patients with angina pectoris","volume":"33","author":"Takazoe","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.jacc.2015.02.040_bib66","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2015.02.040_bib67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1538-7836.2008.03249.x","article-title":"The activation peptide of thrombin-activatable fibrinolysis inhibitor: a role in activity and stability of the enzyme?","volume":"7","author":"Marx","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib68","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","article-title":"Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis","volume":"26","author":"Collet","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.02.040_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0049-3848(96)00064-3","article-title":"D-dimers are degraded by human neutrophil elastase","volume":"82","author":"Bach-Gansmo","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib70","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2008.000042","article-title":"Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins","volume":"94","author":"Semeraro","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jacc.2015.02.040_bib71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0049-3848(93)90241-F","article-title":"Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets","volume":"72","author":"Torr-Brown","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.1990.tb07796.x","article-title":"The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease","volume":"75","author":"Simpson","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2015.02.040_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1253\/jcj.64.547","article-title":"Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction","volume":"64","author":"Soeki","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacc.2015.02.040_bib74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.thromres.2008.04.017","article-title":"Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation","volume":"123","author":"Katsaros","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib75","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11239-013-0962-4","article-title":"Attenuation of spontaneous thrombolytic activity measured by the global thrombosis test in male habitual smokers","volume":"37","author":"Suehiro","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib76","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00001721-200312000-00016","article-title":"Impaired spontaneous thrombolytic activity in elderly and in habitual smokers, as measured by a new global thrombosis test","volume":"14","author":"Ikarugi","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.thromres.2011.06.019","article-title":"Impaired spontaneous thrombolytic activity measured by global thrombosis test in males with metabolic syndrome","volume":"129","author":"Suehiro","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib78","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-6386(98)70145-3","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease","volume":"32","author":"Levey","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2015.02.040_bib79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000187209","article-title":"Plasma parameters of the prothrombotic state in chronic uremia","volume":"63","author":"Sagripanti","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.jacc.2015.02.040_bib80","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2141.2011.08885.x","article-title":"Management of major trauma haemorrhage: treatment priorities and controversies","volume":"155","author":"Davenport","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2015.02.040_bib81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MOT.0b013e3283005832","article-title":"Current approach to intraoperative monitoring in liver transplantation","volume":"13","author":"Krenn","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jacc.2015.02.040_bib82","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1213\/00000539-199902000-00016","article-title":"Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery","volume":"88","author":"Shore-Lesserson","year":"1999","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2015.02.040_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2012.07.001","article-title":"Postpartum hemorrhage management in 2012: predicting the future","volume":"119","author":"Onwuemene","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jacc.2015.02.040_bib84","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1537-2995.2012.03728.x","article-title":"How do we integrate thromboelastography with perioperative transfusion management?","volume":"53","author":"MacIvor","year":"2013","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2015.02.040_bib85","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1111\/trf.12032","article-title":"Pathogenesis of acute traumatic coagulopathy","volume":"53","author":"Davenport","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.jacc.2015.02.040_bib86","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/bja\/86.4.575","article-title":"Reduced haemostatic factor transfusion using heparinase-modified thromboelastography during cardiopulmonary bypass","volume":"86","author":"Royston","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2015.02.040_bib87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-2143(97)90040-8","article-title":"Monitoring platelet glycoprotein IIb\/IIIa-fibrin interaction with tissue factor-activated thromboelastography","volume":"130","author":"Khurana","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jacc.2015.02.040_bib88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/09537100701329162","article-title":"A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography","volume":"18","author":"Hobson","year":"2007","journal-title":"Platelets"},{"key":"10.1016\/j.jacc.2015.02.040_bib89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mbc.0000169225.31173.19","article-title":"Multi-centre investigation on reference ranges for ROTEM thromboelastometry","volume":"16","author":"Lang","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib90","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MBC.0b013e32833464e9","article-title":"Tissue\u00a0plasminogen activator induced fibrinolysis: standardization of method using thromboelastography","volume":"21","author":"Kupesiz","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib91","doi-asserted-by":"crossref","first-page":"e55175","DOI":"10.1371\/journal.pone.0055175","article-title":"Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses","volume":"8","author":"Willeit","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jacc.2015.02.040_bib92","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1538-7836.2009.03574.x","article-title":"Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men","volume":"7","author":"Wannamethee","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib93","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1373\/clinchem.2007.090969","article-title":"Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study","volume":"54","author":"Chien","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2015.02.040_bib94","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.02.040_bib95","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/ATVBAHA.113.302479","article-title":"Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease","volume":"33","author":"Nestel","year":"2013","journal-title":"Aterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.02.040_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2014.05.417","article-title":"Elevated lipoprotein(a) has incremental prognostic value in Type 2 Diabetic patients with symptomatic coronary artery disease","author":"Kwon","year":"2014","journal-title":"J Atheroscler Thrombo"},{"key":"10.1016\/j.jacc.2015.02.040_bib97","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ijcard.2012.05.007","article-title":"Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients","volume":"167","author":"Kwon","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib98","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11239-014-1075-4","article-title":"PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease","volume":"38","author":"Rosser","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000315494","article-title":"Platelet function and spontaneous thrombolytic activity of patients with cerebral infarction assessed by the global thrombosis test","volume":"37","author":"Taomoto","year":"2010","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.jacc.2015.02.040_bib100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000319067","article-title":"Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study","volume":"30","author":"Canoui-Poitrine","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2015.02.040_bib101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations between lipoprotein (a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"125","author":"Virani","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib102","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jacc.2013.09.042","article-title":"Lipoprotein(a) for risk assessment in patients with established coronary artery disease","volume":"63","author":"O\u2019Donoghue","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib103","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.296.11.1363","article-title":"Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women","volume":"296","author":"Suk Danik","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.02.040_bib104","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.02.040_bib105","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.283.14.1845","article-title":"Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause","volume":"283","author":"Shilpak","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.02.040_bib106","doi-asserted-by":"crossref","first-page":"e003103","DOI":"10.1161\/JAHA.112.003103","article-title":"Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study","volume":"2","author":"Zamani","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2015.02.040_bib107","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.thromres.2004.12.007","article-title":"The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project","volume":"116","author":"Nordenhem","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2015.02.040_bib108","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.ATV.19.3.493","article-title":"Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study","volume":"19","author":"Cushman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.02.040_bib109","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.ATV.0000249406.92992.0d","article-title":"Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study","volume":"26","author":"Morange","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2015.02.040_bib110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1538-7836.2008.03221.x","article-title":"Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study","volume":"7","author":"Tregouet","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib111","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2004.12.015","article-title":"Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER)","volume":"180","author":"Gaw","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2015.02.040_bib112","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","article-title":"Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data","volume":"168","author":"Bennet","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2015.02.040_bib113","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1160\/TH13-08-0643","article-title":"Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes","volume":"111","author":"Jeong","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2015.02.040_bib114","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ahj.2010.05.034","article-title":"Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events","volume":"160","author":"Gurbel","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.02.040_bib115","first-page":"631","article-title":"Earlier application of loading doses of aspirin and clopidogrel decreases rate of recurrent cardiovascular ischemic events for patients undergoing percutaneous coronary intervention","volume":"125","author":"Tang","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jacc.2015.02.040_bib116","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/09537100802687666","article-title":"The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting","volume":"20","author":"Gurbel","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.jacc.2015.02.040_bib117","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib118","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","article-title":"Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary interventionis the current antiplatelet therapy adequate?","volume":"49","author":"Bliden","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.02.040_bib119","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MBC.0b013e3282ff76ae","article-title":"Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting","volume":"19","author":"Gurbel","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jacc.2015.02.040_bib120","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3760\/cma.j.issn.0366-6999.20123360","article-title":"Effects of coexisting polymorphisms of CYP2C19 and P2Y12 on clopidogrel responsiveness and clinical outcome in patients with acute coronary syndromes undergoing stent-based coronary intervention","volume":"126","author":"Tang","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jacc.2015.02.040_bib121","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1253\/circj.CJ-12-0635","article-title":"Association of CYP2C19 genotype with periprocedural myocardial infarction after uneventful stent implantation in Chinese patients receiving clopidogrel pretreatment","volume":"76","author":"Wu","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2015.02.040_bib122","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/13685538.2012.666584","article-title":"The prevalence, risk factors and prognosis of aspirin resistance in elderly male patients with cardiovascular disease","volume":"15","author":"Cao","year":"2012","journal-title":"Aging Male"},{"key":"10.1016\/j.jacc.2015.02.040_bib123","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00228-012-1446-8","article-title":"Effect of the CYP2C19*2 and *3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention","volume":"69","author":"Tang","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2015.02.040_bib124","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1076029613485411","article-title":"Hypercoagulation assessed by thromboelastography is neither related to infarct size nor to clinical outcome after primary percutaneous coronary intervention","volume":"20","author":"Dridi","year":"2013","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715007305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715007305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T14:05:25Z","timestamp":1717855525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715007305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":124,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0735109715007305"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.02.040","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous Fibrinolysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.02.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}